- Home
- BNTX vs DVN Comparison
BNTX vs DVN Comparison
Compare BNTX & DVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- DVN
- Stock Information
- Founded
- BNTX 2008
- DVN 1971
- Country
- BNTX Germany
- DVN United States
- Employees
- BNTX N/A
- DVN N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- DVN Oil & Gas Production
- Sector
- BNTX Health Care
- DVN Energy
- Exchange
- BNTX Nasdaq
- DVN Nasdaq
- Market Cap
- BNTX 23.9B
- DVN 25.4B
- IPO Year
- BNTX 2019
- DVN N/A
- Fundamental
- Price
- BNTX $117.67
- DVN $37.28
- Analyst Decision
- BNTX Strong Buy
- DVN Buy
- Analyst Count
- BNTX 14
- DVN 21
- Target Price
- BNTX $141.60
- DVN $51.47
- AVG Volume (30 Days)
- BNTX 1.2M
- DVN 8.5M
- Earning Date
- BNTX 11-04-2024
- DVN 11-05-2024
- Dividend Yield
- BNTX N/A
- DVN 3.82%
- EPS Growth
- BNTX N/A
- DVN N/A
- EPS
- BNTX N/A
- DVN 5.41
- Revenue
- BNTX $3,390,698,192.00
- DVN $14,529,000,000.00
- Revenue This Year
- BNTX N/A
- DVN $9.80
- Revenue Next Year
- BNTX N/A
- DVN $8.11
- P/E Ratio
- BNTX N/A
- DVN $7.01
- Revenue Growth
- BNTX N/A
- DVN N/A
- 52 Week Low
- BNTX $76.53
- DVN $37.28
- 52 Week High
- BNTX $131.49
- DVN $55.09
- Technical
- Relative Strength Index (RSI)
- BNTX 57.29
- DVN 40.69
- Support Level
- BNTX $101.02
- DVN $37.28
- Resistance Level
- BNTX $121.80
- DVN $38.37
- Average True Range (ATR)
- BNTX 5.74
- DVN 0.87
- MACD
- BNTX 1.63
- DVN -0.03
- Stochastic Oscillator
- BNTX 85.79
- DVN 15.04
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About DVN Devon Energy Corporation
Devon Energy is an oil and gas producer with acreage in several top US shale plays. While roughly two thirds of its production comes from the Permian Basin, it also holds a meaningful presence in the Anadarko, Eagle Ford, and Bakken basins. At the end of 2023, Devon reported net proved reserves of 1.8 billion barrels of oil equivalent. Net production averaged roughly 658,000 barrels of oil equivalent per day in 2023 at a ratio of 73% oil and natural gas liquids and 27% natural gas.